Acadia Healthcare Company Inc.
| 61.35 | -0.1700 | -0.28% | Vol 15.53K | 1Y Perf 180.90% |
| Apr 23rd, 2021 10:00 DELAYED |
| BID | 61.34 | ASK | 61.55 | ||
| Open | 61.88 | Previous Close | 61.52 | ||
| Pre-Market | - | After-Market | - | ||
| - -% | - - |
| Target Price | 57.86 | Analyst Rating | Moderate Buy 2.30 | |
| Potential % | -5.96 | Finscreener Ranking | + 37.87 | |
| Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | + 37.95 | |
| Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | + 27.49 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
| Market Cap | 5.49B | Earnings Rating | Neutral | |
| Price Range Ratio 52W % | 96.05 | Earnings Date | 29th Apr 2021 |
Today's Price Range 60.6561.88 | 52W Range 21.2763.00 | 5 Year PE Ratio Range -12.50603.80 |
Summary:
Buy
| Technical Indicators: | Buy |
| Moving Averages: | Strong Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | -0.97% | ||
| 1 Month | 11.81% | ||
| 3 Months | 18.28% | ||
| 6 Months | 97.24% | ||
| 1 Year | 180.90% | ||
| 3 Years | 62.92% | ||
| 5 Years | -2.86% | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -4.33 | |||
ROE last 12 Months | -29.05 | |||
ROA (5Y Avg) | -1.52 | |||
ROA last 12 Months | -9.61 | |||
ROC (5Y Avg) | 0.49 | |||
ROC last 12 Months | 3.80 | |||
Return on invested Capital Q | -13.30 | |||
Return on invested Capital Y | -9.67 | |||
Assets Turnover | 0.20 | |||
Receivables Turnover | 3.80 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -8.10 | ||||
| 2.92 | ||||
| 4.16 | ||||
| 8.40 | ||||
| 11.90 | ||||
| 7.44 | ||||
| -20.25 | ||||
| 21.24 | ||||
| 8.43B | ||||
| Forward PE | 22.67 | |||
| PEG | -0.63 |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.50 | ||||
| 1.90 | ||||
| 0.62 | ||||
| 1.71 | ||||
| 2.20 | ||||
| Leverage Ratio | 3.00 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 95.80 | ||||
| 16.40 | ||||
| 20.90 | ||||
| 4.40 | ||||
| -57.83 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.31B | ||||
| 14.62 | ||||
| -9.07 | ||||
| 1.35 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2020 | 0.69 | 1.13 | 63.77 |
| Q03 2020 | 0.55 | 0.68 | 23.64 |
| Q02 2020 | 0.38 | 0.54 | 42.11 |
| Q01 2020 | 0.37 | 0.42 | 13.51 |
| Q04 2019 | 0.49 | 0.51 | 4.08 |
| Q03 2019 | 0.53 | 0.52 | -1.89 |
| Q02 2019 | 0.59 | 0.61 | 3.39 |
| Q01 2019 | 0.35 | 0.39 | 11.43 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 3/2021 QR | 0.45 | -13.46 | Negative |
| 6/2021 QR | 0.59 | -10.61 | Negative |
| 12/2021 FY | 2.35 | -11.32 | Negative |
| 12/2022 FY | 2.74 | -4.53 | Negative |
| Next Report Date | 29th Apr 2021 |
| Estimated EPS Next Report | 0.45 |
| Estimates Count | 4 |
| EPS Growth Next 5 Years % | 12.80 |
| Volume Overview | |
|---|---|
| Volume | 15.53K |
| Shares Outstanding | 89.41M |
| Trades Count | 151 |
| Dollar Volume | 39.42M |
| Avg. Volume | 577.68K |
| Avg. Weekly Volume | 411.28K |
| Avg. Monthly Volume | 445.06K |
| Avg. Quarterly Volume | 594.09K |
Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 61.52 per share at the end of the most recent trading day (a -1.65% change compared to the prior day closing price) with a volume of 476.75K shares and market capitalization of 5.49B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.
The one-year performance of Acadia Healthcare Company Inc. stock is 180.9%, while year-to-date (YTD) performance is 22.4%. ACHC stock has a five-year performance of -2.86%. Its 52-week range is between 21.27 and 63, which gives ACHC stock a 52-week price range ratio of 96.05%
Acadia Healthcare Company Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 2.92, a price-to-sale (PS) ratio of 4.16, a price to cashflow ratio of 8.40, a PEG ratio of 2.32, a ROA of -9.61%, a ROC of 3.80% and a ROE of -29.05%. The company’s profit margin is -57.83%, its EBITDA margin is 20.90%, and its revenue ttm is $1.31 Billion , which makes it $14.62 revenue per share.
Of the last four earnings reports from Acadia Healthcare Company Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 29th Apr 2021.
The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2.3), with a target price of $57.86, which is -5.96% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Acadia Healthcare Company Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.80, ATR14 : 2.21, CCI20 : 139.61, Chaikin Money Flow : 0.08, MACD : 2.37, Money Flow Index : 67.70, ROC : 4.98, RSI : 62.25, STOCH (14,3) : 76.40, STOCH RSI : 0.25, UO : 60.00, Williams %R : -23.60), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were: Christopher L. Howard (Option Excercise at a value of $382 402), Christopher L. Howard (Sold 33 228 shares of value $1 930 214 ), David Duckworth (Option Excercise at a value of $426 432), David Duckworth (Sold 18 780 shares of value $1 089 991 ), Reeve B. Waud (Sold 354 065 shares of value $12 799 201 ), William F. Grieco (Option Excercise at a value of $33 000), William F. Grieco (Sold 4 000 shares of value $239 340 )
Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
CEO: Debra K. Osteen
Telephone: +1 615 861-6000
Address: 6100 Tower Circle, Franklin 37067, TN, US
Number of employees: 42 800
